Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1357045 | Leflunomide Related Compound A - 4-trifluoromethyl)aniline | 100 mg |
| USP-1357056 | Leflunomide Related Compound B - 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide | 10 mg |
| USP-1357067 | Leflunomide Related Compound C - N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide | 10 mg |
| USP-1357475 | Latanoprost | 50 mg |
| USP-1357486 | Latanoprost Related Compound A - Isopropy l(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)- 3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate | 50 mg |
| USP-1357497 | Latanoprost Related Compound B | 25 mg |
| USP-1357522 | Latanoprost Related Compound D | 25 mg |
| USP-1357533 | Latanoprost Related Compound E - (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid | 25 mg |
| USP-1358004 | Leucovorin Calcium | 500 mg |
| USP-1358503 | Leuprolide Acetate (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 200 mg |
| USP-1358784 | Levalbuterol Hydrochloride (HCl) | 200 mg |
| USP-1358795 | Levalbuterol Related Compound A - 4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol | 30 mg |
| USP-1358809 | Levalbuterol Related Compound B - alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol | 20 mg |
| USP-1358810 | Levalbuterol Related Compound C - alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol | 30 mg |
| USP-1358820 | Levalbuterol Related Compound D - 5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde benzenesulfonic acid salt | 30 mg |
| USP-1358831 | Levalbuterol Related Compound E - alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol | 30 mg |
| USP-1358842 | Levalbuterol Related Compound F - alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol | 30 mg |
| USP-1358864 | Levalbuterol Related Compound H - 4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol | 5 mg |
| USP-1359302 | Levamisole Hydrochloride (HCl) | 125 mg |
| USP-1359404 | Levetiracetam | 200 mg |
| USP-1359415 | Levetiracetam Racemic Mixture | 15 mg |
| USP-1359426 | Levetiracetam Related Compound A - (S)-N(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide | 20 mg |
| USP-1359437 | Levetiracetam Related Compound B - (S)-2-aminobutanamide Hydrochloride (HCl) | 20 mg |
| USP-1359801 | Levobunolol Hydrochloride (HCl) | 200 mg |
| USP-1359856 | Levocabastine Hydrochloride (HCl) | 50 mg |
| USP-1359867 | Levocabastine Related Compound A - 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride | 50 mg |
| USP-1359903 | Levocarnitine | 400 mg |
| USP-1359925 | Levocarnitine Related Compound A - 2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-,chloride | 100 mg |
| USP-1361009 | Levodopa | 200 mg |
| USP-1361010 | Levodopa Related Compound A - 3-(3,4,6-Trihydroxyphenyl)-alanine | 50 mg |
| USP-1362103 | Levofloxacin | 200 mg |
| USP-1362114 | Levofloxacin Related Compound A - (S)-9-fluoro-2,3-dihydro-3-methyl-10-(piperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid | 25 mg |
| USP-1362125 | Levofloxacin Related Compound B - (S)-9,10,difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid | 35 mg |
| USP-1362136 | Levofloxacin Related Compound C - (S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate | 25 mg |
| USP-1362307 | Levomenol | 100 mg |
| USP-1362500 | Levonordefrin | 200 mg |
| USP-1362602 | Levonorgestrel | 125 mg |
| USP-1363004 | This item has been discontinued - Levopropoxyphene Napsylate | 300 mg |
| USP-1365000 | Levothyroxine | 500 mg |
| USP-1365021 | Levothyroxine for Peak Identification levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid | 15 mg |
| USP-1365065 | Levothyroxine Sodium | 50 mg |
| USP-1366002 | Lidocaine | 250 mg |
| USP-1367005 | Lincomycin Hydrochloride | 200 mg |
| USP-1367504 | Lindane | 200 mg |
| USP-1367561 | Linezolid | 200 mg |
| USP-1367570 | ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | 20 mg |
| USP-1367581 | ((S)-N-{[3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide) | 20 mg |
| USP-1367592 | ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | 20 mg |
| USP-1367708 | Linoleoyl Polyoxylglycerides | 100 mg |
| USP-1368008 | Liothyronine | 250 mg |
| USP-1368201 | Alpha Lipoic Acid | 500 mg |
| USP-1368609 | Lisinopril | 300 mg |
| USP-1368610 | Lisinopril Related Compound A - ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl}-4-phenylbutanoic acid | 15 mg |
| USP-1369000 | Lithium Carbonate | 300 mg |
| USP-1369419 | Lomustine | 200 mg |
| USP-1369431 | Lomustine Related Compound B - (1-(2-Chloroethyl)-3-cyclohexylurea) | 25 mg |
| USP-1369442 | Lomustine Related Compound C - (1,3-Dicyclohexylurea) | 25 mg |
| USP-1369453 | Lomustine Related Compound D - (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) | 25 mg |
| USP-1370000 | Loperamide Hydrochloride (HCl) | 200 mg |
| USP-1370101 | Lopinavir | 350 mg |
| USP-1370156 | Lopinavir System Suitability Mixture | 10 mg |
| USP-1370203 | Loracarbef | 200 mg |
| USP-1370225 | Loracarbef L-Isomer | 25 mg |
| USP-1370269 | Loratadine Related Compound C - 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one | 15 mg |
| USP-1370270 | Loratadine | 200 mg |
| USP-1370280 | Loratadine Related Compound A - 8-chloro-6,11-dihydro-11(4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine | 15 mg |
| USP-1370291 | Loratadine Related Compound B - 8-chloro-6,11-dihydro-11-(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine | 15 mg |
| USP-1370338 | Lorazepam Related Compound B - 2-Amino-2',5-dichlorobenzophenone | 25 mg |
| USP-1370349 | Lorazepam Related Compound C - 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde | 25 mg |
| USP-1370350 | Lorazepam Related Compound D - 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid | 25 mg |
| USP-1370360 | Lorazepam Related Compound E - 6-Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol | 25 mg |
| USP-1370462 | Losartan Potassium | 150 mg |
| USP-1370600 | Lovastatin | 125 mg |
| USP-1370611 | Lovastatin Related Compound A - Dihydro-lovastatin | 20 mg |
| USP-1370702 | Loxapine Succinate | 125 mg |
| USP-1370713 | Loxapine Related Compound A - 3-Chloro-11-(4-methylpiperazine-1-yl)dibenzo[b,f][1,4]oxazepine | 20 mg |
| USP-1370746 | Lumefantrine | 100 mg |
| USP-1370757 | Lumefantrine Related Compound A - (RS,Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol | 25 mg |
| USP-1370804 | Lutein | 3 x 50 mg |
| USP-1370860 | Lycopene | 500 mg |
| USP-1370906 | Lynestrenol | 20 mg |
| USP-1371501 | L-Lysine Acetate | 200 mg |
| USP-1372005 | L-Lysine Hydrochloride (HCl) | 200 mg |
| USP-1372050 | Lysophosphatidylcholine (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 250 mg |
| USP-1372402 | Polyoxyl Lauryl Ether | 500 mg |
| USP-1372424 | Polyoxyl 4 Lauryl Ether | 1 mL |
| USP-1372468 | Polyoxyl 23 Lauryl Ether | 0,5 g |
| USP-1372504 | Polyoxyl Oleate | 500 mg |
| USP-1372606 | Polyoxyl 10 Stearyl Ether | 1 g |
| USP-1373008 | Mafenide Acetate | 200 mg |
| USP-1374000 | Magaldrate | 200 mg |
| USP-1374226 | Magnesium Carbonate | 2 g |
| USP-1374248 | Magnesium Chloride | 1 g |
| USP-1374260 | Magnesium Hydroxide | 1 g |
| USP-1374292 | Magnesium Phosphate | 2 g |
| USP-1374306 | Magnesium Salicylate | 200 mg |
| USP-1374340 | Magnesium Stearate (AS) | 5 g |
| USP-1374361 | Magnesium Sulfate (AS) | 1 g |
| USP-1374383 | Powdered Malabar-Nut-Tree Leaf Extract | 1 g |
| USP-1374408 | Malathion | 500 mg |